Combination therapy of Lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells

Journal of Microbiology and Biotechnology

Volumn 26, Issue 8, 2016, Pages 1490-1503

  An, Jaejin ^a   Ha, Eun Mi ^b  

^a Medical Convergence Textile Center   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

5 fluorouracil; Cancer stem cells; Chemoresistant; Colorectal cancer cells; Lactobacillus plantarum

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BETA CATENIN; CASPASE 3; CD133 ANTIGEN; FLUOROURACIL; HERMES ANTIGEN; PROBIOTIC AGENT; WNT PROTEIN; ALCAM PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; AXIN; AXIN1 PROTEIN, HUMAN; CULTURE MEDIUM; FETOPROTEIN; ISOENZYME; LEUKOCYTE ANTIGEN; NERVE CELL ADHESION MOLECULE; PROM1 PROTEIN, HUMAN; RETINAL DEHYDROGENASE; TANKYRASE; TNKS PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL SURVIVAL; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; LACTOBACILLUS PLANTARUM; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SUPERNATANT; CANCER STEM CELL; CHEMISTRY; COLORECTAL TUMOR; CULTURE MEDIUM; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HCT 116 CELL LINE; HT-29 CELL LINE; METABOLISM; WNT SIGNALING PATHWAY;

AC133 ANTIGEN; ANTIGENS, CD; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; APOPTOSIS; AXIN PROTEIN; BETA CATENIN; CASPASE 3; CELL ADHESION MOLECULES, NEURONAL; COLORECTAL NEOPLASMS; CULTURE MEDIA; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FETAL PROTEINS; FLUOROURACIL; HCT116 CELLS; HT29 CELLS; HUMANS; ISOENZYMES; LACTOBACILLUS PLANTARUM; NEOPLASTIC STEM CELLS; POLYMERASE CHAIN REACTION; PROBIOTICS; RETINAL DEHYDROGENASE; TANKYRASES; WNT SIGNALING PATHWAY;

EID: 84984851122     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1605.05024     Document Type: Article

References (96)

1. Abreu MT, Peek RM Jr. 2014. Gastrointestinal malignancy and the microbiome. Gastroenterology 146: 1534-1546.
2. Altonsy MO, Andrews SC, Tuohy KM. 2010. Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. Int. J. Food Microbiol. 137: 190-203.
3. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. 2004. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New Engl. J. Med. 350: 2343-2351.
4. Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, Hole N, Lako M. 2004. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22: 1142-1151.
5. Azcarate-Peril MA, Sikes M, Bruno-Barcena JM. 2011. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am. J. Physiol. Gastrointest. Liver Physiol. 301: G401-G424.
6. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307: 1915-1920.
7. Bao R, Christova T, Song S, Angers S, Yan X, Attisano L. 2012. Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells. PLoS One 7: e48670.
8. Barker N, Clevers H. 2006. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 5: 997-1014.
9. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N. 2008. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76: 907-915.
10. Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. 2011. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin. Infect. Dis. 53: 870-878.
11. Boman BM, Huang E. 2008. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J. Clin. Oncol. 26: 2828-2838.
12. Bowen JM, Gibson RJ, Cummins AG, Keefe DM. 2006. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support. Care Cancer 14: 713-731.
13. Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C. 2011. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit. Rev. Microbiol. 37: 1-14.
14. Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, Brigidi P. 2014. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J. Gastroenterol. 20: 908-922.
15. Carbonero F, Benefiel AC, Gaskins HR. 2012. Contributions of the microbial hydrogen economy to colonic homeostasis. Nat. Rev. Gastroenterol. Hepatol. 9: 504-518.
16. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22: 299-306.
17. Center MM, Jemal A, Smith RA, Ward E. 2009. Worldwide variations in colorectal cancer. CA Cancer J. Clin. 59: 366-378.
18. Center MM, Jemal A, Ward E. 2009. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prevent. 18: 1688-1694.
19. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, et al. 2009. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5: 100-107.
20. Chen W, Liu F, Ling Z, Tong X, Xiang C. 2012. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 7: e39743.
21. Clevers H. 2006. Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
22. Clinton SK, Bostwick DG, Olson LM, Mangian HJ, Visek WJ. 1988. Effects of ammonium acetate and sodium cholate on N-methyl-N’-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res. 48: 3035-3039.
23. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. 2010. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Nat. Acad. Sci. USA 107: 11537-11542.
24. Curtin JC, Lorenzi MV. 2010. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 1: 552-566.
25. Dalerba P, Clarke MF. 2007. Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell 1: 241-242.
26. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc. Nat. Acad. Sci. USA 104: 10158-10163.
27. Dean M, Fojo T, Bates S. 2005. Tumour stem cells and drug resistance. Nat.Rev. Cancer 5: 275-284.
28. Dick JE. 2008. Stem cell concepts renew cancer research. Blood 112: 4793-4807.
29. Du L, Wang H, He L, Zhang J, Ni B, Wang X, et al. 2008. CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res. 14: 6751-6760.
30. Dulal S, Keku TO. 2014. Gut microbiome and colorectal adenomas. Cancer J. 20: 225-231.
31. Gao Z, Guo B, Gao R, Zhu Q, Wu W, Qin H. 2015. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. Mol. Med. Rep. 12: 6119-6127.
32. Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, et al. 2010. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J. Gastroenterol. 16: 167-175.
33. Gibson RJ, Keefe DM. 2006. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support. Care Cancer 14: 890-900.
34. Goessling W, North TE, Loewer S, Lord AM, Lee S, StoickCooper CL, et al. 2009. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136: 1136-1147.
35. Greer JB, O’Keefe SJ. 2011. Microbial induction of immunity, inflammation, and cancer. Front. Physiol. 1: 168.
36. Grivennikov SI, Karin M. 2010. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21: 11-19.
37. Guarner F, Malagelada JR. 2003. Gut flora in health and disease. Lancet 361: 512-519.
38. Ha EM. 2016. Escherichia coli-derived uracil increases the antibacterial activity and growth rate of Lactobacillus plantarum. J. Microbiol. Biotechnol. 26: 975-987
39. Haggar FA, Boushey RP. 2009. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin. Colon Rectal Surg. 22: 191-197.
40. Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I. 2014. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J. Gastroenterol. 20: 1192-1210.
41. Hope ME, Hold GL, Kain R, El-Omar EM. 2005. Sporadic colorectal cancer - role of the commensal microbiota. FEMS Microbiol. Lett. 244: 1-7.
42. Horvat M, Krebs B, Potrc S, Ivanecz A, Kompan L. 2010. Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien. Klin. Wochenschr. Suppl. 2: 26-30.
43. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, et al. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620.
44. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, et al. 2005. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116: 762-767.
45. Ivanov K, Kolev N, Tonev A, Nikolova G, Krasnaliev I, Softova E, Tonchev A. 2009. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience. Hepatogastroenterology 56: 94-98.
46. Jamieson C, Sharma M, Henderson BR. 2011. Regulation of beta-catenin nuclear dynamics by GSK-3beta involves a LEF-1 positive feedback loop. Traffic 12: 983-999.
47. Jemal A, Center MM, Ward E, Thun MJ. 2009. Cancer occurrence. Methods Mol. Biol. 471: 3-29.
48. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J. Clin. 58: 71-96.
49. Jimenez-Anula J, Luque RJ, Gaforio JJ, Delgado M. 2005. [Prognostic value of invasive growth pattern in sporadic colorectal cancer]. Cir. Esp. 77: 337-342.
50. Jones ML, Martoni CJ, Ganopolsky JG, Labbe A, Prakash S. 2014. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin. Biol. Ther. 14: 467-482.
51. Jordan CT, Guzman ML, Noble M. 2006. Cancer stem cells. New Engl. J. Med. 355: 1253-1261.
52. -/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J. Immunol. 178: 6522-6532.
53. Keku TO, Dulal S, Deveaux A, Jovov B, Han X. 2015. The gastrointestinal microbiota and colorectal cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 308: G351-G363.
54. Kim Y, Oh S, Yun HS, Kim SH. 2010. Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells. Lett. Appl. Microbiol. 51: 123-130.
55. Kimelman D, Xu W. 2006. Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25: 7482-7491.
56. Kumar RS, Kanmani P, Yuvaraj N, Paari KA, Pattukumar V, Thirunavukkarasu C, Arul V. 2012. Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1,2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl. Biochem. Biotechnol. 166: 620-631.
57. Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW. 2003. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 1: E10.
58. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
59. Liu Z, Qin H, Yang Z, Xia Y, Liu W, Yang J, et al. 2011. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Aliment. Pharmacol. Ther. 33: 50-63.
60. Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM. 2007. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat. Rev. 33: 448-460.
61. Longley DB, Harkin DP, Johnston PG. 2003. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3: 330-338.
62. MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17: 9-26.
63. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
64. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M. 2009. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1140-G1149.
65. Michaelson JS, Leder P. 2001. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20: 5093-5099.
66. Migliore L, Migheli F, Spisni R, Coppede F. 2011. Genetics, cytogenetics, and epigenetics of colorectal cancer. J. Biomed. Biotechnol. 2011: 792362.
67. Mizrak D, Brittan M, Alison M. 2008. CD133: molecule of the moment. J. Pathol. 214: 3-9.
68. Najdi R, Holcombe RF, Waterman ML. 2011. Wnt signaling and colon carcinogenesis: beyond APC. J. Carcinog. 10: 5.
69. Nugent JL, McCoy AN, Addamo CJ, Jia W, Sandler RS, Keku TO. 2014. Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J. Proteome Res. 13: 1921-1929.
70. Nyangale EP, Mottram DS, Gibson GR. 2012. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J. Proteome Res. 11: 5573-5585.
71. Oh PS, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, et al. 2011. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 301: G347-G355.
72. Prisciandaro LD, Geier MS, Butler RN, Cummins AG, Howarth GS. 2011. Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis. Crit. Rev. Food Sci. Nutr. 51: 239-247.
73. Prosperi JR, Goss KH. 2010. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer. Curr. Drug Targets 11: 1074-1088.
74. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, et al. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85: 488-496.
75. Ramasamy S, Singh S, Taniere P, Langman MJ, Eggo MC. 2006. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G288-G296.
76. Recchia F, Rea S, Nuzzo A, Lalli A, Di Lullo L, De Filippis S, et al. 2004. Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer. Anticancer Res. 24: 1935-1940.
77. Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
78. Ribble D, Goldstein NB, Norris DA, Shellman YG. 2005. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 5: 12.
79. Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. 2007. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br. J. Nutr. 97: 676-684.
80. Salic A, Lee E, Mayer L, Kirschner MW. 2000. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the Wnt pathway in Xenopus egg extracts. Mol. Cell 5: 523-532.
81. Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, et al. 2012. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J. 6: 1858-1868.
82. Schwabe RF, Wang TC. 2012. Cancer. Bacteria deliver a genotoxic hit. Science 338: 52-53.
83. Stringer AM, Gibson RJ, Bowen JM, Keefe DM. 2009. Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change. Curr. Drug Metab. 10: 79-83.
84. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Burns J, Keefe DM. 2007. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp. Biol. Med. (Maywood) 232: 96-106.
85. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Hamilton J, Keefe DM. 2009. Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp. Biol. Med. (Maywood) 234: 430-441.
86. Strus M, Janczyk A, Gonet-Surowka A, Brzychczy-Wloch M, Stochel G, Kochan P, Heczko PB. 2009. Effect of hydrogen peroxide of bacterial origin on apoptosis and necrosis of gut mucosa epithelial cells as a possible pathomechanism of inflammatory bowel disease and cancer. J. Physiol. Pharmacol. 6: 55-60.
87. Tamboli CP, Neut C, Desreumaux P, Colombel JF. 2004. Dysbiosis in inflammatory bowel disease. Gut 53: 1-4.
88. Turashvili G, Bouchal J, Burkadze G, Kolar Z. 2006. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 73: 213-223.
89. Verkaar F, Zaman GJ. 2011. New avenues to target Wnt/ beta-catenin signaling. Drug Discov. Today 16: 35-41.
90. Waaler J, Machon O, Tumova L, Dinh H, Korinek V, Wilson SR, et al. 2012. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Cancer Res. 72: 2822-2832.
91. Wang X, Huycke MM. 2007. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132: 551-561.
92. Weichert W, Knosel T, Bellach J, Dietel M, Kristiansen G. 2004. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J. Clin. Pathol. 57: 1160-1164.
93. Welch JP, Donaldson GA. 1979. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann. Surg. 189: 496-502.
94. Wend P, Holland JD, Ziebold U, Birchmeier W. 2010. Wnt signaling in stem and cancer stem cells. Semin. Cell Dev. Biol. 21: 855-863.
95. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. 2013. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66: 462-470.
96. Zhong L, Zhang X, Covasa M. 2014. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J. Gastroenterol. 20: 7878-7886.